It has already been shown that MSCs have also the ability to inhibit NF-kB in tumor cells (Table 1).214 Furthermore, MSCs can inhibit the proliferation-related signaling pathways through paracrine actions (Figure 3). The gene discussed is NFKB1; the disease is neoplasm.